Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8991938 | 1.00 | PTGS2 (0.41) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL8978903 | 0.75 | PTGS2 (0.55) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL8978913 | 0.75 | PTGS2 (0.55) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL8962158 | 0.73 | PTGS2 (0.56) | PTGS2PTGS1SMN1; SMN2NPSR1LMNA | |
| SCHEMBL8895686 | 0.73 | MEN1 (0.40) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL8991924 | 0.73 | MEN1 (0.40) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL8962160 | 0.73 | PTGS2 (0.56) | PTGS2PTGS1SMN1; SMN2NPSR1LMNA | |
| SCHEMBL8908613 | 0.71 | PTGS2 (0.41) | PTGS2PTGS1SMN1; SMN2NPSR1ALOX5 | |
| SCHEMBL3263474 | 0.71 | PTGS2 (0.64) | PTGS2PTGS1ALOX5GAA | |
| SCHEMBL3263476 | 0.71 | PTGS2 (0.64) | PTGS2PTGS1ALOX5GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0722729-A2 | Aryl-substituted rhodanines for treating multiple sclerosis | ELI LILLY AND COMPANY (US) | 1996-07-24 | — | — | EP | disclosed |